A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

NCT01004315 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: KUC-7483
DRUG: Placebo
DRUG: Tolterodine

Sponsor

Kissei Pharmaceutical Co., Ltd.